UK study finds mRNA COVID-19 vaccines provide biggest booster impact

Read more

Amgen announces positive top-line results from Otezla phase-III Discreet study in moderate-to-severe genital psoriasis

Read more

Novavax says it could start making Omicron-specific vaccine in January

Read more

Biocon gets US FDA nod for generic product

Read more

Moderna COVID vaccine highly effective five months after second dose: Study

Read more

ZyCoV-D to be used in seven states initially

Read more

Thermo Fisher Scientific’s TaqPath COVID-19 Tests can detect the presence of the Omicron variant in SARS-CoV-2 samples

Read more

Antibody drug works against COVID-19 Omicron variant: GSK

Read more

Serum Institute seeks DCGI’s approval for Covishield as booster dose

Read more

Gilead and AWS collaborate on development and delivery of new medicines for patients

Read more